Wednesday, March 23, 2022
10:01 AM EST – NeonMind Biosciences Inc. : Announced today it is setting up to offer low dose intravenous ketamine therapy for mood and anxiety disorders (IV-Ket) as an initial treatment at its recently announced, inaugural specialty mental health clinic location in Mississauga, Ontario, pending clinic licensing. NeonMind Biosciences Inc. (C.NEON) shares were unchanged at 0.06.
Stocks in Play: NeonMind Biosciences Inc., Wed, 23 Mar 2022 10:12:07 EST